Litigation Details for Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-11-04 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 8,568,747 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-02-09 | 213 | Opinion - Memorandum Opinion | Azurity’s patent related to the Epaned Kit is U.S. Patent No. 8,568,747 (the ’747 patent), which was…infringes U.S. Patent Nos. 10,786,482 (the ’482 patent) and 10,918,621 (the ’621 patent), both titled … the ’482 patent and claims 4, 7, 17, and 18 of the ’621 patent. Claim 4 of the ’621 patent is illustrative…23, and 28 of the ’482 patent and claims 4, 7, 17, and 18 of the ’621 patent. Alkem denies infringement…. for a drug claimed in a patent or the use of which is claimed in a patent[.]” 35 U.S.C. § 271(e)(2) | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
